InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by STARR KEVIN P, Director. Insider active across 1 company, notably Sage Therapeutics, Inc.. In total, 2 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €1.7m. History available since 16 June 2021. The latest transaction was filed on 16 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
17,842 shares@ US$56.046650.0% of flowCommon StockSEC:0001562180-21-004343
Ideal exit: 13 Mar 2022 (T+270)
17,842 shares@ US$56.046650.0% of flowCommon StockSEC:0001562180-21-004343:0
Ideal exit: 13 Mar 2022 (T+270)
2 of 2 declarations
About STARR KEVIN P
Kevin P. Starr is a Board Member at Sage Therapeutics, Inc. He plays a key role in the strategic direction of the company, ensuring it adheres to best practices in governance. His experience in the healthcare sector is an asset for innovation initiatives.
